The evaluation of latent tuberculosis in rheumatologic diseases for anti-TNF therapy: Experience with 192 patients

Clinical Rheumatology

Volumn 27, Issue 9, 2008, Pages 1083-1086

  Hanta, Ismail ^a   Ozbek, Suleyman ^a   Kuleci, Sedat ^a   Kocabas, Ali ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Anti TNF therapy; Latent tuberculosis infection; Tuberculin skin test

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; ISONIAZID; METHOTREXATE; PYRIDOXINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC VALUE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOUS LYMPHADENITIS;

ADULT; ANTIBODIES; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; RADIOGRAPHY, THORACIC; SPONDYLITIS, ANKYLOSING; TUBERCULIN TEST; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48449086842     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-0867-3     Document Type: Article

References (21)

1. Ellerin T, Rubin RH, Weinblatt ME (2003) Infections and anti tumor necrosis factor a therapy. Arthritis Rheum 48:3013-3022
2. Kroesen S, Widmer AF, Tyndall A et al (2003) Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF alpha therapy. Rheumatology (Oxford) 42(5):617-621
3. Long R, Gardam M (2003) Tumour necrosis factor-α inhibitors and the reactivation of latent tuberculosis infection. CMAJ 168(9):1153-1156
4. Mutlu G, Mutlu E, Bellmeyer A et al (2006) Pulmonary adverse events of anti tumour necrosis factor-a antibody therapy. Am J Med 119:639-646
5. Huebner RE, Schein MF, Bass JBJ (1993) The tuberculin skin test. Clin Infect Dis 17:968-975
6. American Thoracic Society (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 61:S221-S247
7. British Thoracic Society Standards of Care Committee (2005) BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment. Thorax 60:800-805
8. Iliopoulos A, Psathakis K, Aslanidis S et al (2006) Tuberculosis and granuloma formation in patients receiving anti-TNF therapy. Int Tuberc Lung Dis 10(5):588-590
9. Nizam S, Emery P (2006) Attenuated response to purified protein derivative in patients with rheumatoid arthritis. Ann Rheum Dis 65:980
10. Emery P, Panayi G, Symmons D et al (1984) Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis: The role of protein energy malnutrition. Ann Rheum Dis 43:430-434
11. Ponce de Leon D, Acevedo-Vasquez E, Sanchez-Torres A et al (2005) Attenuated response to purified protein derivative in patients with rheumatoid arthritis: Study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 64:1360-1361
12. Andersen P, Munk ME, Pollock JM et al (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356:1099-1104
13. Kang YA, Lee HW, Yoon HI et al (2005) Discrepancy between the tuberculin skin test and the whole-blood interferon assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 293:2756-2761
14. Sichletidis L, Settas L, Spyratos D et al (2006) Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis. Int J Tuberc Lung Dis 10(10):1127-1132
15. Hanta I, Ozbek S, Kuleci S et al (2007) Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFα. Clin Rheumatol 26(11):1867-1870
16. Manadan AM, Joyce K, Sequeira W et al (2007) Etanercept therapy in patients with a positive tuberculin skin test. Clin Exp Rheumatol 25(5):743-745
17. Gomez-Reino JJ, Carmano L, Descalzo A, BIOBADASER GROUP (2007) Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 57(5):756-761
18. Mohan AK, Cote TR, Block JA et al (2004) Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis 39:295-299
19. Dimakou K, Papaioannides D, Latsi P et al (2004) Disseminated tuberculosis complicating anti-TNF-α treatment. Int J Clin Pract 58(11):1052-1055
20. Stas P, D'Hoore A, Van Assche G et al (2006) Miliary tuberculosis following infliximab therapy for Crohn disease: A case report and review of the literature. Acta Gastroenterol Belg 69(29):217-220
21. Mayardomo L, Marenco JL, Gomez-Mateos J et al (2002) Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment. Scand J Rheumatol 31(1):44-45